ARPC4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-06980
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-ERHNKPEVEVR corresponding to internal region according to NP_005709.1.
Epitope
internal region
Specificity
This antibody is expected to recognise isoform a ( NP_005709.1).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for ARPC4 Antibody
Western Blot: ARPC4 Antibody [NBP1-06980]
Western Blot: ARPC4 Antibody [NBP1-06980] - Analysis of ARPC4 in Human Lymph Node lysate (35ug protein in RIPA buffer) using this antibody at 0.03 ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.Applications for ARPC4 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:64000
Western Blot
0.01 - 0.03 ug/ml
Application Notes
WB: Approx. 19 kDa band observed in human lymph node lysates (calculated MW of 19.7 kDa band according to NP_005709.1).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: ARPC4
Alternate Names
actin related protein 2/3 complex, subunit 4, 20kDa, actin-related protein 2/3 complex subunit 4, arp2/3 protein complex subunit p20, MGC13544, p20-ARC, subunit 4 (20 kD)
Gene Symbol
ARPC4
UniProt
Additional ARPC4 Products
Product Documents for ARPC4 Antibody
Product Specific Notices for ARPC4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...